New York, New York-- (Newsfile Corp. - November 15, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation ...

As other companies introduce innovative valve designs and delivery systems, Edwards may face challenges in maintaining its dominant position. Furthermore, the company's growth in the TAVR segment ...

As the company strives to maintain its dominant position in the Transcatheter Aortic Valve Replacement (TAVR) market while expanding into new territories, investors and analysts are closely watching ...

Hospital heart team capacity constraints continued to limit Edwards Lifesciences’ transcatheter aortic valve replacement ...

Analysts said the findings complicate the outlook for a U.S. launch of Boston Scientific's aortic valve replacement device.

Edwards Lifesciences Corp., Orange County’s most valuable publicly traded medical device maker, reported third quarter sales ...

New York, New York-- (Newsfile Corp. - November 14, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation ...

Hospital heart team capacity constraints continued to limit Edwards Lifesciences’ transcatheter aortic valve replacement (TAVR) sales in the third quarter of 2024, company executives said ...

( MENAFN - GlobeNewsWire - Nasdaq) Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly ...

Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit ...

New York, New York--(Newsfile Corp. - November 13, 2024) - Faruqi & Faruqi, LLP, a leading national securities law firm, is ...

The TAVR market, which has been a key driver ... mitral, and tricuspid valves, Edwards could strengthen its relationships with healthcare providers and potentially capture a larger share of ...